The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses

Journal of General Virology

Volumn 93, Issue 3, 2012, Pages 565-576

  Fehrholz, Markus ^a   Kendl, Sabine ^a   Prifert, Christiane ^a   Weissbrich, Benedikt ^a   Lemon, Ken ^b   Rennick, Linda ^c   Duprex, Paul W ^c   Rima, Bert K ^b   Koning, Fransje A ^d   Holmes, Rebecca K ^d   Malim, Michael H ^d   Schneider Schaulies, Jürgen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADENOSINE DEAMINASE ACTING ON THE RNA; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE; GUANINE; UNCLASSIFIED DRUG; URIDINE; VIRUS ENZYME; VIRUS RNA;

ARTICLE; CATALYSIS; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; MEASLES VIRUS; MUMPS VIRUS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VERO CELL; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTIDINE DEAMINASE; HUMANS; MEASLES VIRUS; MUMPS VIRUS; POINT MUTATION; RESPIRATORY SYNCYTIAL VIRUSES; RNA, VIRAL; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HEPATITIS B VIRUS; PNEUMOVIRUS; RNA VIRUSES;

EID: 84857082722     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.038919-0     Document Type: Article

References (64)

1. Aguiar, R. S. & Peterlin, B. M. (2008). APOBEC3 proteins and reverse transcription. Virus Res 134, 74-85.
2. Baczko, K., Lampe, J., Liebert, U. G., Brinckmann, U., Ter-Meulen, V., Pardowitz, I., Budka, H., Cosby, S. L., Isserte, S. & Rima, B. K. (1993). Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197, 188-195.
3. Bankamp, B., Wilson, J., Bellini, W. J. & Rota, P. A. (2005). Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 336, 120-129.
4. Bass, B. L. (2002). RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71, 817-846.
5. Bishop, K. N., Holmes, R. K., Sheehy, A. M. & Malim, M. H. (2004). APOBEC-mediated editing of viral RNA. Science 305, 645.
6. Bishop, K. N., Holmes, R. K. & Malim, M. H. (2006). Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol 80, 8450-8458.
7. Bishop, K. N., Verma, M., Kim, E. Y., Wolinsky, S. M. & Malim, M. H. (2008). APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog 4, e1000231.
8. Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain-Hobson, S.(2006). Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43, 1364-1374.
9. Bulliard, Y., Turelli, P., Röhrig, U. F., Zoete, V., Mangeat, B., Michielin, O. & Trono, D. (2009). Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J Virol 83, 12611-12621.
10. Burnett, A. & Spearman, P. (2007). APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J Virol 81, 5000-5013.
11. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., Ter-Meulen, V. & Billeter, M. A. (1988). Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55, 255-265.
12. Chambers, P., Rima, B. K. & Duprex, W. P. (2009). Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol 90, 2973-2981.
13. Chelico, L., Sacho, E. J., Erie, D. A. & Goodman, M. F. (2008). A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J Biol Chem 283, 13780-13791.
14. Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R. & Weitzman, M. D. (2006). APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 16, 480-485.
15. Chen, H., Wang, L. W., Huang, Y. Q. & Gong, Z. J. (2010). Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo. Int J Mol Sci 11, 3501-3512.
16. + T cells. Nature 435, 108-114.
17. Chiu, Y. L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T. & Greene, W. C. (2006). High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A 103, 15588-15593.
18. Conticello, S. G. (2008). The AID/APOBEC family of nucleic acid mutators. Genome Biol 9, 229.
19. Duprex, W. P., Duffy, I., McQuaid, S., Hamill, L., Cosby, S. L., Billeter, M. A., Schneider-Schaulies, J., Ter-Meulen, V. & Rima, B. K. (1999). The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol 73, 6916-6922.
20. Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M. & Malim, M. H. (2007). Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81, 2165-2178.
21. Gallois-Montbrun, S., Holmes, R. K., Swanson, C. M., Fernández-Ocaña, M., Byers, H. L., Ward, M. A. & Malim, M. H. (2008). Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol 82, 5636-5642.
22. Hallak, L. K., Spillmann, D., Collins, P. L. & Peeples, M. E. (2000). Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74, 10508-10513.
23. Han, Y., Wang, X., Dang, Y. & Zheng, Y. H. (2008). APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication. PLoS Pathog 4, e1000095.
24. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S. & Malim, M. H. (2003). DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809.
25. Hashimoto, K., Ono, N., Tatsuo, H., Minagawa, H., Takeda, M., Takeuchi, K. & Yanagi, Y. (2002). SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76, 6743-6749.
26. Holmes, R. K., Malim, M. H. & Bishop, K. N. (2007). APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32, 118-128.
27. Hotta, H., Nihei, K., Abe, Y., Kato, S., Jiang, D. P., Nagano-Fujii, M. & Sada, K. (2006). Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE. Microbiol Immunol 50, 525-534.
28. Huthoff, H. & Malim, M. H. (2007). Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation. J Virol 81, 3807-3815.
29. Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F. & Malim, M. H. (2009). RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog 5, e1000330.
30. Iwatani, Y., Chan, D. S., Wang, F., Maynard, K. S., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K. & Levin, J. G. (2007). Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 35, 7096-7108.
31. + T cells. J Virol 75, 7973-7986.
32. Khan, M. A., Kao, S., Miyagi, E., Takeuchi, H., Goila-Gaur, R., Opi, S., Gipson, C. L., Parslow, T. G., Ly, H. & Strebel, K. (2005). Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J Virol 79, 5870-5874.
33. Khan, M. A., Goila-Gaur, R., Opi, S., Miyagi, E., Takeuchi, H., Kao, S. & Strebel, K. (2007). Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. Retrovirology 4, 48.
34. Koning, F. A., Newman, E. N., Kim, E. Y., Kunstman, K. J., Wolinsky, S. M. & Malim, M. H. (2009). Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83, 9474-9485.
35. Kozak, S. L., Marin, M., Rose, K. M., Bystrom, C. & Kabat, D. (2006). The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 281, 29105-29119.
36. Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A. J. (2003). Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112.
37. 2DDCT method. Methods 25, 402-408.
38. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L. & Trono, D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
39. Navaratnam, N., Bhattacharya, S., Fujino, T., Patel, D., Jarmuz, A. L. & Scott, J. (1995). Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81, 187-195.
40. Newman, E. N., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H. & Sheehy, A. M. (2005). Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol 15, 166-170.
41. Parker, R. & Sheth, U. (2007). P bodies and the control of mRNA translation and degradation. Mol Cell 25, 635-646.04
42. Pauli, E. K., Schmolke, M., Hofmann, H., Ehrhardt, C., Flory, E., Münk, C. & Ludwig, S. (2009). High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity. Retrovirology 6, 38.
43. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. (2006). Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203, 41-46.
44. Perreault, J., Noël, J. F., Brié re, F., Cousineau, B., Lucier, J. F., Perreault, J. P. & Boire, G. (2005). Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Res 33, 2032-2041.
45. Plumet, S. & Gerlier, D. (2005). Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J Virol Methods 128, 79-87.
46. Radecke, F., Spielhofer, P., Schneider, H., Kaelin, K., Huber, M., Dötsch, C., Christiansen, G. & Billeter, M. A. (1995). Rescue of measles viruses from cloned DNA. EMBO J 14, 5773-5784.
47. Rennick, L. J., Duprex, W. P. & Rima, B. K. (2007). Measles virus minigenomes encoding two autofluorescent proteins reveal cell to cell variation in reporter expression dependent on viral sequences between the transcription units. J Gen Virol 88, 2710-2718.
48. Reuter, T., Weissbrich, B., Schneider-Schaulies, S. & Schneider-Schaulies, J. (2006). RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J Virol 80, 5951-5957.
49. Sarkis, P. T., Ying, S., Xu, R. & Yu, X. F. (2006). STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-a. J Immunol 177, 4530-4540.
50. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
51. Sheehy, A. M., Gaddis, N. C. & Malim, M. H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9, 1404-1407.
52. Stopak, K., de Noronha, C., Yonemoto, W. & Greene, W. C. (2003). HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12, 591-601.
53. Stopak, K. S., Chiu, Y. L., Kropp, J., Grant, R. M. & Greene, W. C. (2007). Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 282, 3539-3546.
54. Suspé ne, R., Petit, V., Puyraimond-Zemmour, D., Aynaud, M. M., Henry, M., Guétard, D., Rusniok, C., Wain-Hobson, S. & Vartanian, J. P. (2011). Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol 85, 2458-2462.
55. Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W. S. & Pathak, V. K. (2004). Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem 279, 35822-35828.
56. Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y., Ueda, Y., Kodama, Y., Endo, Y., Yamauchi, J., Matsumoto, T. (2006). Anti-viral protein APOBEC3G is induced by interferon-a stimulation in human hepatocytes. Biochem Biophys Res Commun 341, 314-319.
57. Turelli, P., Mangeat, B., Jost, S., Vianin, S. & Trono, D. (2004). Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829.
58. Wang, G. F., Lin, S. Y., Zhang, H., Gao, Y. L., Li, W. Z., Xin, G. & Li, K. S. (2008). APOBEC3F and APOBEC3G have no inhibition and hypermu-tation effect on the human influenza A virus. Acta Virol 52, 193-194.
59. Wedekind, J. E., Gillilan, R., Janda, A., Krucinska, J., Salter, J. D., Bennett, R. P., Raina, J. & Smith, H. C. (2006). Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits. J Biol Chem 281, 38122-38126.
60. Wichroski, M. J., Robb, G. B. & Rana, T. M. (2006). Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2, e41.
61. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P. & Yu, X. F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
62. Zennou, V., Perez-Caballero, D., Göttlinger, H. & Bieniasz, P. D. (2004). APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J Virol 78, 12058-12061.
63. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C. & Gao, L. (2003). The cytidine deaminase CEM15 induces hypermu-tation in newly synthesized HIV-1 DNA. Nature 424, 94-98.
64. Zinke, M., Kendl, S., Singethan, K., Fehrholz, M., Reuter, D., Rennick, L., Herold, M. J. & Schneider-Schaulies, J. (2009). Clearance of measles virus from persistently infected cells by short hairpin RNA. J Virol 83, 9423-9431.